OrbiMed Asia Partners III, L.P. — Form D/A
OrbiMed Asia Partners III, L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2017-06-28. The offering totals $450.0M, of which $431.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2017-06-28
- Form: D/A
- Accession: 0001685093-17-000003
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $450.0M
- Amount sold: $431.5M
- Remaining: $18.5M
- Investors: 95
- Date of first sale: 2017-03-01
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-281414
Issuer
- Name: OrbiMed Asia Partners III, L.P.
- CIK: 0001685093
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2016
- Address: 601 LEXINGTON AVENUE, NEW YORK, NY, 10022
- Phone: 212-739-6400
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| W. Carter Neild | Director | NEW YORK, NY |
| Sven H Borho | Director | New York, NY |
| Sven H Borho | Executive Officer | New York, NY |
| David G Wang | Director | Shanghai, F4 |
| David G Wang | Executive Officer | Shanghai, F4 |
| Jonathan T Silverstein | Director | New York, NY |
| Carl L Gordon | Director | Stamford, CT |
| N/A OrbiMed Advisors III Limited | Executive Officer | New York, NY |
| N/A OrbiMed Advisors III Limited | Promoter | New York, NY |
| Sunny D Sharma | Director | Mumbai, K7 |
| Sunny D Sharma | Executive Officer | Mumbai, K7 |
| Jonathan G Wang | Director | Shanghai, F4 |
| Jonathan G Wang | Executive Officer | Shanghai, F4 |
| N/A OrbiMed Asia GP III, L.P. | Executive Officer | New York, NY |
| N/A OrbiMed Asia GP III, L.P. | Promoter | New York, NY |
| Samuel D Isaly | Director | New York, NY |
| Samuel D Isaly | Promoter | New York, NY |
Other filings by this issuer (3)
More